Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?
作者信息
Gupta Ravindra K
机构信息
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK.
出版信息
Nat Rev Immunol. 2021 Jun;21(6):405. doi: 10.1038/s41577-021-00560-9.
Abstract
摘要
相似文献
1
Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?作者更正：新型冠状病毒变异株是否会影响疫苗的前景？
Nat Rev Immunol. 2021 Jun;21(6):405. doi: 10.1038/s41577-021-00560-9.
2
SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）突变、疫苗与免疫：关注变异株的影响
Signal Transduct Target Ther. 2021 May 22;6(1):203. doi: 10.1038/s41392-021-00623-2.
3
Author Correction: Development of a model-inference system for estimating epidemiological characteristics of SARS-CoV-2 variants of concern.作者更正：用于估计新冠病毒变异株流行病学特征的模型推理系统的开发。
Nat Commun. 2021 Dec 16;12(1):7360. doi: 10.1038/s41467-021-27703-9.
4
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
5
Author Correction: Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants.作者更正：对美国新冠病毒（SARS-CoV-2）突变的分析表明存在四种亚毒株和新型变体。
Commun Biol. 2021 Mar 3;4(1):311. doi: 10.1038/s42003-021-01867-y.
6
Author Correction: SARS-CoV-2 and HIV-1 - A Tale of Two Vaccines.
Nat Rev Immunol. 2022 Jan;22(1):66. doi: 10.1038/s41577-021-00671-3.
7
Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).基于免疫信息学设计针对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的基于表位的亚单位疫苗。
Immunobiology. 2020 May;225(3):151955. doi: 10.1016/j.imbio.2020.151955. Epub 2020 May 11.
8
Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents.影响来自多个大洲人群队列中 SARS-CoV-2 受体 TMPRSS2 表达的遗传变异。
Biochem Biophys Res Commun. 2020 Aug 20;529(2):263-269. doi: 10.1016/j.bbrc.2020.05.179. Epub 2020 Jun 8.
9
Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.作者更正：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突糖蛋白在病毒进入过程中的特性及其与严重急性呼吸综合征冠状病毒（SARS-CoV）的免疫交叉反应性
Nat Commun. 2021 Apr 1;12(1):2144. doi: 10.1038/s41467-021-22614-1.
10
Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2.作者更正：受体组分析确定KREMEN1和ASGR1为严重急性呼吸综合征冠状病毒2的替代功能受体。
Cell Res. 2022 Jun;32(6):600. doi: 10.1038/s41422-022-00654-6.
引用本文的文献
1
Discovery of Hybrid Thiouracil-Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus's Polymerase "RdRp" as a Confirmed Interacting Biomolecule.发现新型硫脲-香豆素杂合共轭物作为潜在的新型抗SARS-CoV-2药物，其靶向病毒的聚合酶“RdRp”这一已确认的相互作用生物分子。
ACS Omega. 2023 Jul 14;8(30):27056-27066. doi: 10.1021/acsomega.3c02079. eCollection 2023 Aug 1.
2
Development of COVID 19 vaccine: A summarized review on global trials, efficacy, and effectiveness on variants.COVID-19 疫苗的研发：全球试验、对变异株的疗效和效果的综述评价。
Diabetes Metab Syndr. 2022 Apr;16(4):102482. doi: 10.1016/j.dsx.2022.102482. Epub 2022 Apr 8.
3
Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China.中国合肥地区新型冠状病毒变异株的鉴定及其临床意义
Front Med (Lausanne). 2022 Jan 10;8:784632. doi: 10.3389/fmed.2021.784632. eCollection 2021.
4
5
SARS-CoV-2 Lambda (C.37): An emerging variant of concern?严重急性呼吸综合征冠状病毒2型拉姆达变异株（C.37）：一种新出现的值得关注的变异株？
Gene Rep. 2021 Dec;25:101378. doi: 10.1016/j.genrep.2021.101378. Epub 2021 Oct 4.
Zotero 插件